Skip to main content
Log in

General pharmacology of IY-80843, a new H2-receptor antagonist: Effects on the central nervous and cardiovascular systems

  • Research Articles
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

IY-80843, N-[2-(2-Methoxyphenyl)ethyl]-N′-[4-(Imidazole-4-yl) phenyl] formamidine, is a new potent H2-receptor antagonist. The potential secondary pharmacologic effects of this agent, on the central nervous and cardiovascular systems were studied. IY-80843 caused ptosis, suppression of locomotion, hypothermia, prolongation of sleeping time and hypotensive effects in mice, rats and dogs. These results suggest that IY-80843 affects the function of the central nervous and cardiovascular systems in a dose-dependent manner.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References Cited

  • Bemis, K., Bendele, A., Clemens, J. Deldar, A. Gidda, J. General pharmacology of nizatidine in animals. Arzneim.-Forsch. 39(1) Nr. 2 (1989).

    Google Scholar 

  • Chiverton, SG, Hunt, R.H. Medical regimens in short and long-term ulcer management.Clin. Gastroenterol. 2, 255–676 (1988).

    Google Scholar 

  • Domschke, S., Domschke, W. New histamine H2-receptor antagonist.Hepato-Gastroenterology 27(3), 163–168 (1980).

    PubMed  CAS  Google Scholar 

  • Dunham, N. W. and Miya, T. S. A note on a simple apparatus of detecting neurological deficit in rats and mice.J. Amer. pharm. Ass. 10, 208–209 (1957).

    Google Scholar 

  • Epstein, CM., Klopper, J. Ranitidine headache. Headache. 25, 392–393 (1985).

    Article  PubMed  CAS  Google Scholar 

  • Guay, DRF., Metzke, CR. Hypotension after intravenous cimetidine in intensive care unit patients.Anesthesiology 65, 130 Letter. (1986).

    Article  PubMed  CAS  Google Scholar 

  • Irwin, S., In Nodine, J. H. and Siegler, P. E. (Eds) Animal and clinical Pharmacologic techniques in Drug Evaluation. Yearbook Medical publishers, Chicago, 1964, pp. 36–54.

    Google Scholar 

  • Ireland, A., Gear, P., Colin-Jones, DG., Goldding, PL. Ramage JK. Ranitidine 150 mg twice daily vs 300 mg nightly in treatment of duodenal ulcer. Lancet II, 274–275 (1984).

    Article  Google Scholar 

  • Kim, Y. I., Kim, D. Y., Song, Y. H. N-methoxyphenyl Alkyl-N′-Imidazolylphenyl amidine derivatives. Korean patent. Registration No. 94-1776 (1994).

  • Sabbatini, F., Lazzaroni, M., Petrillo, M., Piai, G. Comparative study of mifentidine and ranitidine in the short-term treatment of duodenal ulcer.Eur. J. Clin. Parmacol. 39, 515–517 (1990).

    CAS  Google Scholar 

  • Smith, C., Bardgett, D., Hunter, J. Hemodynamic effect of intravenous administration of cimetidine or ranitidine in the critically ill patient.Br. J. Anesthesiol. 59, 1397–1402 (1987).

    Article  CAS  Google Scholar 

  • Susumu, O. and Yoichi, N. Effects of famotidine, a histamine H2-receptor antagonist, on gastric secretion and gastric and duodenal lesions in rats.Parmacometrics, 27(3), 563–569 (1984).

    Google Scholar 

  • Susumu, O., Hamyo, K. and Hiroshi, O. Effects of a new histamine H2-receptor antagonist, ranitidine, on experimental acute gastric and duodenal ulcers.Folia pharmacol. Japan 77, 397–406 (1981).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, E.J., Shin, H.S., Ryu, S.Y. et al. General pharmacology of IY-80843, a new H2-receptor antagonist: Effects on the central nervous and cardiovascular systems. Arch. Pharm. Res. 18, 1–7 (1995). https://doi.org/10.1007/BF02976498

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02976498

Key words

Navigation